Nasdaq:US$18.44 (+1.50) | HKEX:HK$28.35 (+1.45) | AIM:£2.90 (+0.14)
Search Result
Previous Article   |   Next Article
公告及新闻稿, 其他业务 | 17 Apr 2014

Chi-Med and Sinopharm complete regulatory approval for the establishment of new China drug distribution and marketing Joint Venture